COVID-19 vaccine study in young cancer and transplant patients completed
NCT ID NCT05164016
First seen Jan 06, 2026 · Last updated May 17, 2026 · Updated 24 times
Summary
This study looked at how well COVID-19 vaccines work in children and young adults (under 24) with cancer or who have had a transplant or cellular therapy. Researchers measured antibody and T-cell responses after vaccination. The goal was to understand immune protection in these vulnerable groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Le Bonheur
Memphis, Tennessee, 38103, United States
-
LeBonheur
Memphis, Tennessee, 38103, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.